Achilles Therapeutics plc
ACHL · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$16 | -$12,267 | -$18,792 |
| Dep. & Amort. | – | $1,178 | $1,179 | $1,158 |
| Deferred Tax | – | $0 | $0 | -$3,712 |
| Stock-Based Comp. | – | $1,312 | $1,387 | $1,396 |
| Change in WC | – | -$3 | -$7,804 | $2,008 |
| Other Non-Cash | – | -$19,800 | $3,755 | $3,716 |
| Operating Cash Flow | – | -$17 | -$17,495 | -$14,225 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$0 | -$695 | -$46 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | -$36 | $0 | $0 |
| Investing Cash Flow | – | -$36 | -$695 | -$46 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $5 | -$0 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $0 | $0 | $0 |
| Financing Cash Flow | – | $0 | $5 | -$0 |
| Forex Effect | – | $0 | -$1,022 | $5,636 |
| Net Chg. in Cash | – | -$17,191 | -$19,217 | -$8,599 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $112 | $131,539 | $140,138 |
| End Cash | – | $95 | $112,322 | $131,539 |
| Free Cash Flow | – | -$17 | -$18,190 | -$14,271 |